Modified Viral Capsids Rational Design Reproducibility

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for designing viral capsids are limited by serial infectivity, chimeras generated during production, and the randomness of the process, leading to low reproducibility and limited insights into the functional properties of the capsids.

Innovation Solution

A systematic approach is applied to select candidate polypeptides with desired properties, encode their fragments, and insert them into viral vectors, allowing for tailored screening to identify fragments that confer specific properties to the viral particles, such as increased tropism and infectivity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If directed evolution with serial infectivity is used to generate viral capsids, then functional capsids can be obtained through multiple generations of screening, but the process is random, unreproducible, and generates chimeras requiring multiple screening generations

Engineering Contradiction:
ImprovereproducibilityVSAvoidscreening process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies preliminary action by pre-defining the capsid modification strategy based on rational design principles before initiating the screening process. The capsid modifications are planned in advance according to known structural and functional constraints, eliminating the need for random mutagenesis and multiple screening generations. This approach ensures reproducibility while reducing the complexity of the overall process.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent changes the fundamental parameter of capsid design from random mutation to systematic modification based on rational design. By altering the approach from directed evolution to rational design with predefined modification rules, the process becomes reproducible and eliminates the need for multiple screening generations, directly addressing the reliability and complexity issues.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If rational design with systematic changes is applied to viral capsids, then functional stringency is improved, but diversity and functional potential are restricted

Engineering Contradiction:
Improvefunctional stringencyVSAvoidfunctional diversity
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent applies segmentation by dividing the capsid into modular domains and regions that can be independently modified. This allows systematic changes to be applied to specific segments while maintaining the overall capsid structure and functionality. The modular approach enables functional stringency through targeted modifications while preserving diversity through combinatorial possibilities of segment arrangement and variation.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent applies local quality by making specific, targeted modifications to particular regions of the capsid based on their known functional roles. Instead of uniform systematic changes, the approach applies different modifications to different local regions according to their specific requirements, thereby maintaining functional stringency in critical areas while allowing diversity in less critical regions.

Inventive Principle:
Principle #3Local quality

3Adaptability or versatility

If random mutagenesis is used to generate capsid variants, then diversity of sequences is achieved, but the fraction of valid in frame amino-acid substitutions is very small

Engineering Contradiction:
Improvesequence diversityVSAvoidfraction of valid substitutions
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

The patent changes the parameter of sequence generation from random mutagenesis to systematic modification based on rational design. By altering the fundamental approach to capsid engineering, the process achieves both diversity and high productivity of valid substitutions, eliminating the need to rely on random chance for generating functional variants.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20250051396A1Modified viral capsids
Publication Date: 2025.02.13 BRAVE BIOSCIENCE AB
  • US20250051396A1 patent drawing
  • US20250051396A1 patent drawing
  • US20250051396A1 patent drawing

AI summary

Provided are methods for identifying polypeptides that when displayed on a capsid confer a desired property to viral particles including such capsids, as well as methods for designing and manufacturing viral vectors and viral particles with improved properties.